PL EN
The role of vitamin D, calcium, and phosphorus in the primary prevention of osteoporosis
 
Więcej
Ukryj
1
Students’ Scientific Club, Department of Human Nutrition, Faculty of Public Health in Bytom, Medical University of Silesia, Katowice, Poland
 
2
Doctoral School, Medical University of Silesia, Katowice, Poland
 
3
Department of Human Nutrition, Faculty of Public Health in Bytom, Medical University of Silesia, Katowice, Poland
 
 
Autor do korespondencji
Maksymilian Dobosz   

Studenckie Koło Naukowe, Zakład Żywienia Człowieka, ul. Jordana 19, 41-808 Zabrze, tel. +48 32 275 51 95, e-mail: maksymiliandobosz582@gmail.com
 
 
 
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Most current scientific research focuses primarily on pharmacological methods of treating osteoporosis. Few researchers pay attention to the need to systematize preventive measures. One such measure is an appropriate diet. The intake of adequate nutrients can significantly improve bone mineral density and reduce the risk of developing the disease. The aim of this article was to analyze the available scientific literature on the efficacy and safety of the use of specific nutrients in patients with osteoporosis. This paper is a narrative review based on electronic databases (PubMed, ScienceDirect, Google Scholar), covering mainly literature from 2016–2026. A total of 87 carefully selected publications were included in the detailed analysis. The greatest body of evidence points to the potential positive effects of combined vitamin D and calcium supplementation. When calcium supplements are used as monotherapy, the possible negative effects of these compounds on the cardiovascular system should be taken into account. Excessive dietary phosphorus intake may have adverse effects on the skeletal system.
INFORMACJE O RECENZOWANIU
Sprawdzono w systemie antyplagiatowym
REFERENCJE (86)
1.
Poduval M, Vishwanathan K. Definition and Evolution of the Term Osteoporosis. Indian J Orthop. 2023;57(Suppl 1):42–44. doi: 10.1007/s43465-023-01013-2.
 
2.
Barnsley J, Buckland G, Chan PE, Ong A, Ramos AS, Baxter M, et al. Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. Aging Clin Exp Res. 2021;33(4):759–773. doi: 10.1007/s40520-021-01817-y.
 
3.
Ye C, Ebeling P, Kline G. Osteoporosis. Lancet. 2025;406(10514):2003–2016. doi: 10.1016/S0140-6736(25)01385-6. Epub 2025 Sep 11. Erratum in: Lancet. 2025;406(10514):1952. doi: 10.1016/S0140-6736(25)02130-0.
 
4.
Gregson CL, Armstrong DJ, Avgerinou C, Bowden J, Cooper C, Douglas L, et al. The 2024 UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2025;20(1):119. doi: 10.1007/s11657-025-01588-3.
 
5.
Rizzoli R, Chevalley T. Nutrition and Osteoporosis Prevention. Curr Osteoporos Rep. 2024;22(6):515–522. doi: 10.1007/s11914-024-00892-0.
 
6.
Dobosz M, Ficoń W, Całyniuk B. Osteoporosis – the silent epidemic of the 21st century. Pomeranian J Life Sci. 2026;72(1):30–36. doi: 10.21164/pomjlifesci.1225.
 
7.
Rizzoli R, Biver E, Brennan-Speranza TC. Nutritional intake and bone health. Lancet Diabetes Endocrinol. 2021;9(9):606–621. doi: 10.1016/S2213-8587(21)00119-4.
 
8.
Pai MV. Osteoporosis Prevention and Management. J Obstet Gynaecol India. 2017;67(4):237–242. doi: 10.1007/s13224-017-0994-3.
 
9.
Morin SN, Feldman S, Funnell L, Giangregorio L, Kim S, McDonald-Blumer H, et al. Clinical practice guideline for management of osteoporosis and fracture prevention in Canada: 2023 update. CMAJ. 2023;195(39):E1333–E1348. doi: 10.1503/cmaj.221647.
 
10.
Reddy P, Jialal I. Biochemistry, Fat Soluble Vitamins. [Updated 2022 Sep 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/b....
 
11.
Benedik E. Sources of vitamin D for humans. Int J Vitam Nutr Res. 2022;92(2):118–125. doi: 10.1024/0300-9831/a000733.
 
12.
Bruins MJ. Contribution of different vitamin D forms and fortified foods to vitamin D intake in Europe: A narrative review. J Steroid Biochem Mol Biol. 2025;251:106761. doi: 10.1016/j.jsbmb.2025.106761.
 
13.
Iwaszkiewicz C, Leszczyński P. The Significance of Vitamin D in Adult Orthopaedics and Traumatology. Ortop Traumatol Rehabil. 2023;25(5):279–285. doi: 10.5604/01.3001.0053.9676.
 
14.
Łabądź D, Skolarczyk J, Pekar J, Nieradko-Iwanicka B. Analysis of the influence of selected elements on the functioning of the bone tissue. J Educ Health Sport. 2017;7(4):202–209. doi: 10.5281/zenodo.400815.
 
15.
Pilz S, Pludowski P, Kraus DA, Schmitt L, Riedmann U. The 2024 Endocrine Society Guideline on Vitamin D: Comprehensive Summary and Critical Appraisal. Nutrients. 2026;18(9):1472. doi: 10.3390/nu18091472.
 
16.
Chauhan K, Shahrokhi M, Huecker MR. Vitamin D. [Updated 2023 Apr 9]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/b....
 
17.
Kaur J, Khare S, Givler A. Vitamin D Deficiency. [Updated 2025 Feb 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/b....
 
18.
Chang SW, Lee HC. Vitamin D and health – The missing vitamin in humans. Pediatr Neonatol. 2019;60(3):237–244. doi: 10.1016/j.pedneo.2019.04.007.
 
19.
Cui A, Zhang T, Xiao P, Fan Z, Wang H, Zhuang Y. Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: A pooled analysis of 7.9 million participants. Front Nutr. 2023;10:1070808. doi: 10.3389/fnut.2023.1070808.
 
20.
Harvey NC, Ward KA, Agnusdei D, Binkley N, Biver E, Campusano C, et al. Optimisation of vitamin D status in global populations. Osteoporos Int. 2024;35(8):1313–1322. doi: 10.1007/s00198-024-07127-z.
 
21.
Demay MB, Pittas AG, Bikle DD, Diab DL, Kiely ME, Lazaretti-Castro M, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(8):1907–1947. doi: 10.1210/clinem/dgae290.
 
22.
Normy żywienia dla populacji Polski. Rychlik E, Stoś K, Woźniak A, Mojska H [eds.]. Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy. Warszawa 2024.
 
23.
Kuciński J, Fryska Z, Wołejko A, Semeniuk P, Burczyk R, Górna N, et al. Aktualne zalecenia w Polsce dotyczące suplementacji witaminy D. Med Og Nauk Zdr. 2023;29(4):277–282. doi: 10.26444/monz/176079.
 
24.
Płudowski P, Kos-Kudła B, Walczak M, Fal A, Zozulińska-Ziółkiewicz D, Sieroszewski P, et al. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients. 2023;15(3):695. doi: 10.3390/nu15030695.
 
25.
Bertoldo F, Cianferotti L, Di Monaco M, Falchetti A, Fassio A, Gatti D, et al. Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS). Nutrients. 2022;14(19):4148. doi: 10.3390/nu14194148.
 
26.
Carugo S, Vescini F, Giusti A, Mauro GL, Tafaro L, Festuccia F, et al. The essential role of combined calcium and vitamin D supplementation in the osteoporosis scenario in italy: Expert opinion paper. Arch Osteoporos. 2024;19(1):99. doi: 10.1007/s11657-024-01451-x.
 
27.
Chevalley T, Brandi ML, Cashman KD, Cavalier E, Harvey NC, Maggi S, et al. Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin Exp Res. 2022;34(11):2603–2623. doi: 10.1007/s40520-022-02279-6.
 
28.
Voulgaridou G, Papadopoulou SK, Detopoulou P, Tsoumana D, Giaginis C, Kondyli FS, et al. Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs. Diseases. 2023;11(1):29. doi: 10.3390/diseases11010029.
 
29.
Pascual-Pastor M, Barceló-Bru M. Daily Calcium and Vitamin D Supplementation as a Foundational Pillar in Osteoporosis Management: A Narrative Review. Nutrients. 2026;18(14):2292. doi: 10.3390/nu18142292.
 
30.
Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–58. doi: 10.1210/jc.2010-2704.
 
31.
Taylor PN, Davies JS. A review of the growing risk of vitamin D toxicity from inappropriate practice. Br J Clin Pharmacol. 2018;84(6):1121–1127. doi: 10.1111/bcp.13573.
 
32.
Asif A, Farooq N. Vitamin D Toxicity. [Updated 2023 May 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/b....
 
33.
Janoušek J, Pilařová V, Macáková K, Nomura A, Veiga-Matos J, da Silva DD, et al. Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites. Crit Rev Clin Lab Sci. 2022;59(8):517–554. doi: 10.1080/10408363.2022.2070595.
 
34.
Weaver CM, Peacock M. Calcium. Adv Nutr. 2019;10(3):546–548. doi: 10.1093/advances/nmy086.
 
35.
Calcium content of common foods. International Osteoporosis Foundation, 2026 [online] https://www.osteoporosis.found... [accessed on 15 September 2026].
 
36.
Plantz MA, Bittar K. Dietary Calcium and Supplementation. [Updated 2024 Jul 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/b....
 
37.
Zhang Q, Tang Y, Nie H, Wang X, Wang G, Xiao C. Pharmacological characteristics and solubility profiles of calcium supplement preparations: A comparative study with clinical implications. PharmaNutrition. 2025;35:100470. doi: 10.1016/j.phanu.2025.100470.
 
38.
Reid IR. Calcium Supplementation – Efficacy and Safety. Curr Osteoporos Rep. 2025;23(1):8. doi: 10.1007/s11914-025-00904-7.
 
39.
Shaker JL, Deftos L. Calcium and Phosphate Homeostasis. [Updated 2023 May 17]. In: Feingold KR, Adler RA, Ahmed SF, et al. [eds.]. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/b....
 
40.
Matikainen N, Pekkarinen T, Ryhänen EM, Schalin-Jäntti C. Physiology of Calcium Homeostasis: An Overview. Endocrinol Metab Clin North Am. 2021;50(4):575–590. doi: 10.1016/j.ecl.2021.07.005.
 
41.
Shlisky J, Mandlik R, Askari S, Abrams S, Belizan JM, Bourassa MW, et al. Calcium deficiency worldwide: prevalence of inadequate intakes and associated health outcomes. Ann N Y Acad Sci. 2022;1512(1):10–28. doi: 10.1111/nyas.14758.
 
42.
Anastasopoulou C, Goyal A. Hypocalcemia. [Updated 2026 Jun 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/b....
 
43.
Drake TM, Zubair M. Calcium Homeostasis and Disorders: An Integrated Clinical and Laboratory Approach. [Updated 2026 Jun 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/b....
 
44.
Tinawi M. Disorders of Calcium Metabolism: Hypocalcemia and Hypercalcemia. Cureus. 2021;13(1):e12420. doi: 10.7759/cureus.12420.
 
45.
Rao MN, Shoback DM. Hypocalcemia. [Updated 2018 Jun 2]. In: Feingold KR, Adler RA, Ahmed SF, et al. [eds.]. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/b....
 
46.
Leszczyński P, Iwaszkiewicz C, Żuber ZM, Kwiatkowska B, Batko BP, Pawlak-Buś KK. Diagnosis and treatment of osteoporosis: 2026 recommendations of the Polish Society for Rheumatology. Rheumatology. 2026;64(5):356–376. doi: 10.5114/reum/224406.
 
47.
Goltzman D. Approach to Hypercalcemia. [Updated 2026 Mar 19]. In: Feingold KR, Adler RA, Ahmed SF, et al. [eds.]. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/b....
 
48.
Sadiq NM, Anastasopoulou C, Patel G, Badireddy M. Hypercalcemia. [Updated 2024 May 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/b....
 
49.
Turner JJO. Hypercalcaemia – presentation and management. Clin Med (Lond). 2017;17(3):270–273. doi: 10.7861/clinmedicine.17-3-270.
 
50.
Tonon CR, Silva TAAL, Pereira FWL, Queiroz DAR, Junior ELF, Martins D, et al. A Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hypercalcemia. Med Sci Monit. 2022;28:e935821. doi: 10.12659/MSM.935821.
 
51.
Bolland MJ, Barber PA, Doughty RN, Mason B, Horne A, Ames R, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ. 2008;336(7638):262–266. doi: 10.1136/bmj.39440.525752.BE.
 
52.
Anderson JJ, Kruszka B, Delaney JA, He K, Burke GL, Alonso A, et al. Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification and its Progression Among Older Adults: 10-Year Follow-up of the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Heart Assoc. 2016;5(10):e003815. doi: 10.1161/JAHA.116.003815.
 
53.
Zhang X, Tan KC, Kung AW, Li GH, Cheung CL. Association Between Calcium Supplementation and Recurrence of Cardiovascular Events in Patients With Cardiovascular Disease: A Population-Based Cohort Study. J Am Heart Assoc. 2026;15(8):e047455. doi: 10.1161/JAHA.125.047455.
 
54.
Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115(7):846–854. doi: 10.1161/CIRCULATIONAHA.106.673491. Erratum in: Circulation. 2007;115(19):e466.
 
55.
Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res. 2004;19(3):370–378. doi: 10.1359/JBMR.0301240.
 
56.
Cauley JA, Chlebowski RT, Wactawski-Wende J, Robbins JA, Rodabough RJ, Chen Z, et al. Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative. J Womens Health (Larchmt). 2013;22(11):915–929. doi: 10.1089/jwh.2013.4270.
 
57.
Prince RL, Devine A, Dhaliwal SS, Dick IM. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med. 2006;166(8):869–875. doi: 10.1001/archinte.166.8.869.
 
58.
McClure ST, Chang AR, Selvin E, Rebholz CM, Appel LJ. Dietary Sources of Phosphorus among Adults in the United States: Results from NHANES 2001–2014. Nutrients. 2017;9(2):95. doi: 10.3390/nu9020095.
 
59.
Fulgoni K, Fulgoni VL 3rd. Trends in Total, Added, and Natural Phosphorus Intake in Adult Americans, NHANES 1988–1994 to NHANES 2015–2016. Nutrients. 2021;13(7):2249. doi: 10.3390/nu13072249.
 
60.
Trautvetter U, Ditscheid B, Jahreis G, Glei M. Habitual Intakes, Food Sources and Excretions of Phosphorus and Calcium in Three German Study Collectives. Nutrients. 2018;10(2):171. doi: 10.3390/nu10020171.
 
61.
Kozłowska L. Źródła fosforu w diecie a ryzyko powikłań mineralnych i kostnych u osób z przewlekłą chorobą nerek. Bromat Chem Toksykol. 2012;45(3):822–826.
 
62.
Hernando N, Wagner CA. Mechanisms and Regulation of Intestinal Phosphate Absorption. Compr Physiol. 2018;8(3):1065–1090. doi: 10.1002/cphy.c170024.
 
63.
Kaczkan M, Bienias A, Małgorzewicz S. Realization of low phosphate diet and hidden sources of phosphorus. Forum Nefrol. 2018;11(1):15–23.
 
64.
Wagner CA. The basics of phosphate metabolism. Nephrol Dial Transplant. 2024;39(2):190–201. doi: 10.1093/ndt/gfad188.
 
65.
Lampen A, Lachenmeier DW, Diel P, Ensenauer R, Frommherz L, Guth S, et al. Dietary phosphate exposure-strategies to protect vulnerable population groups. Arch Toxicol. 2026;100(5):1657–1684. doi: 10.1007/s00204-025-04274-y.
 
66.
Biruete A, Hill Gallant KM, Lindemann SR, Wiese GN, Chen NX, Moe SM. Phosphate Binders and Nonphosphate Effects in the Gastrointestinal Tract. J Ren Nutr. 2020;30(1):4–10. doi: 10.1053/j.jrn.2019.01.004.
 
67.
Akimbekov NS, Digel I, Sherelkhan DK, Razzaque MS. Vitamin D and Phosphate Interactions in Health and Disease. Adv Exp Med Biol. 2022;1362:37–46. doi: 10.1007/978-3-030-91623-7_5.
 
68.
St-Jules DE, Jagannathan R, Gutekunst L, Kalantar-Zadeh K, Sevick MA. Examining the Proportion of Dietary Phosphorus From Plants, Animals, and Food Additives Excreted in Urine. J Ren Nutr. 2017;27(2):78–83. doi: 10.1053/j.jrn.2016.09.003.
 
69.
Itkonen ST, Lamberg-Allardt C. Phosphorus – a scoping review for Nordic Nutrition Recommendations 2023. Food Nutr Res. 2023;67. doi: 10.29219/fnr.v67.10318.
 
70.
Ciosek Ż, Kot K, Kosik-Bogacka D, Łanocha-Arendarczyk N, Rotter I. The Effects of Calcium, Magnesium, Phosphorus, Fluoride, and Lead on Bone Tissue. Biomolecules. 2021;11(4):506. doi: 10.3390/biom11040506.
 
71.
Michigami T, Ozono K. Roles of Phosphate in Skeleton. Front Endocrinol (Lausanne). 2019;10:180. doi: 10.3389/fendo.2019.00180.
 
72.
Liu ES. Diagnosis and Management of Hypophosphatemic Disorders. Endocr Pract. 2025;31(12):1592–1600. doi: 10.1016/j.eprac.2025.07.015.
 
73.
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on Dietary Reference Values for phosphorus. EFSA J. 2015;13(7):4185. doi: 10.2903/j.efsa.2015.4185.
 
74.
Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington (DC): National Academies Press (US); 1997. 5, Phosphorus. Available from: https://www.ncbi.nlm.nih.gov/b....
 
75.
Lee AW, Cho SS. Association between phosphorus intake and bone health in the NHANES population. Nutr J. 2015;14:28. doi: 10.1186/s12937-015-0017-0.
 
76.
Itkonen ST, Rita HJ, Saarnio EM, Kemi VE, Karp HJ, Kärkkäinen MU, et al. Dietary phosphorus intake is negatively associated with bone formation among women and positively associated with some bone traits among men–a cross-sectional study in middle-aged Caucasians. Nutr Res. 2017;37:58–66. doi: 10.1016/j.nutres.2016.12.009.
 
77.
Jiang T, Pan Y, Xu J, Ge J, Ji S, Li T, et al. Association between serum phosphorus levels and pelvic bone mineral density in U.S. adults aged 18–59 years. BMC Musculoskelet Disord. 2025;26(1):665. doi: 10.1186/s12891-025-08838-y.
 
78.
Peng YS, Sun WH, Wu HY, Chiu YL, Yang JY, Pai MF, et al. Short-term effects of therapeutic diet on bone turnover markers in hemodialysis patients: an exploratory analysis of a randomized crossover trial. Sci Rep. 2026;16(1):9365. doi: 10.1038/s41598-026-39820-w.
 
79.
Arnst JL, Alappan UD, Viggeswarapu M, Beck GR Jr. Sustained and reversible effects of a dietary phosphate intake on bone and mineral metabolism during aging. Geroscience. 2026;48(1):705–725. doi: 10.1007/s11357-025-01714-6.
 
80.
Hryciuk M, Heleniak Z, Dębska-Ślizień A. Management of chronic kidney disease–mineral and bone disorder. Renal Disease and Transplantation Forum. 2023;16(3):65–80. doi: 10.5603/rdatf.96819.
 
81.
Qadeer HA, Bashir K. Physiology, Phosphate. [Updated 2023 Aug 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/b....
 
82.
Calvo MS, Uribarri J. Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population. Am J Clin Nutr. 2013;98(1):6–15. doi: 10.3945/ajcn.112.053934.
 
83.
Rubio-Aliaga I, Krapf R. Phosphate intake, hyperphosphatemia, and kidney function. Pflugers Arch. 2022;474(8):935–947. doi: 10.1007/s00424-022-02691-x.
 
84.
Salera D, Merkel N, Bellasi A, de Borst MH. Pathophysiology of chronic kidney disease-mineral bone disorder (CKD-MBD): from adaptive to maladaptive mineral homeostasis. Clin Kidney J. 2025;18(Suppl 1):i3–i14. doi: 10.1093/ckj/sfae431.
 
85.
Stróżecki P, Manitius J. Hyperphosphatemia in patients with chronic kidney disease. Forum Nefrol. 2018;11(1):1–8.
 
86.
Rout P, Jialal I. Hyperphosphatemia. [Updated 2023 Jun 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/b....
 
eISSN:1734-025X
Journals System - logo
Scroll to top